Dabur Q2 Results: Profit Rises 3.3%, Margin Beats Estimates
Dabur India Ltd.'s second quarter profit rose in line with analysts' estimates, and margin expanded as it reaped the benefit of moderating inflation.
Consolidated net profit of the Ayurveda products maker rose 3.3% over the previous year to Rs 507.4 crore in the quarter ended September, according to an exchange filing. That compares with the Rs 515.76-crore consensus estimate of analysts tracked by Bloomberg.
The profitability was impacted on account of a one-time legal cost of Rs 36 crore. The lawsuits pertain to hair relaxer products sold by the company's foreign subsidiary—Namaste Laboratories LLC. Net profit, excluding legal costs and amortisation related to Badshah acquisition, grew 14.7%.
Revenue rose 7.3% to Rs 3,203.8 crore, against the projected Rs 3,231.83 crore.
Operating profit increased 10% to Rs 660.9 crore, against the Rs 652.43 crore forecast.
Margin stood at 20.6% versus 20.1%. Analysts had pegged the metric at 20.2%.
Excluding exceptional legal costs, the operating profit surged 16%.
Domestic volume growth stood at 3%. With Badshah, it stands at 5.8%.
Ad spends for the quarter marked a 42.6% growth to Rs 216.5 crore.
The quarterly performance was impacted due to the triple whammy of deficient monsoon, mild summer and a shift in the festive season to the third quarter. This combination of factors has resulted in a dip in the food and beverages revenue during the quarter, even as the healthcare and the home and personal care businesses bucked the trend, the company said.
Segmentwise Highlights (YoY)
Revenue in healthcare business grew 5.4% to Rs 663 crore.
The home and personal care portfolio, which accounts for over half of sales, reported a 5.8% rise in revenue to Rs 1,126 crore.
Revenue in food and beverages declined 7.1% to Rs 400 crore. While the food business grew 40.4%, the beverages category fell 10%.
Dabur Chyawanprash saw muted growth as season was delayed.
New launches contributed 4.3% of the F&B portfolio during Q2.
Badshah spices portfolio recorded 16.4% growth.
Dabur's digestive business, riding on steady performance of its flagship brand Hajmola, grew by 18.1%.
The Ayurvedic over-the-counter and ethicals business rose by 8.1%.
"We have witnessed a marked sequential improvement in urban demand, led by new-age channels," said Mohit Malhotra, chief executive officer of Dabur India. While the rural growth still lags urban demand, the gap has reduced. "We are increasingly optimistic of the future as we are seeing green shoots of recovery in rural sentiments," he said, adding that the company will continue to invest behind its brands, distribution infrastructure and innovation to deliver volume-led profitable growth.
Dabur's international business grew by 23.6% in constant currency terms, driven by Turkey (77.8%), Egypt (35%) and MENA (18.4%), among others.
The company is on track to achieve Rs 500 crore of exit revenue in the food business, including Badshah, it said. Dabur acquired a majority stake in the spices brand Badshah Masala Pvt. earlier this year, in line with its strategic intent of entering into new adjacent categories in the food space.
In Q2, the domestic business saw key brands posting category-leading growth, with market share gains across 90% of the product portfolio.
Market Share Gains
Dabur's baby massage oils gained 90 basis points in market share, while cold and cough segment increased 40 basis points.
Dabur continued to gain market share and drive the herbal segment ahead of non-herbals.
Market share for hair oils portfolio improved by 143 basis points to touch 17%.
Odonil recorded an increase of 160 basis points in market share in air fresheners category, strengthening its leadership position.
Odomos' market share increased by 560 basis points.
"We believe we are on the right path with our strategic playbook," said Malhotra. "We remain focused on managing our business with agility, leveraging our strong distribution footprint, while enhancing our margin, quarter after quarter."
Shares of Dabur India rose 1.47% to Rs 524.7 apiece after the results were declared, as compared with a 0.65% gain in the benchmark BSE Sensex on Thursday.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.